Note that this is summary that we’ve gathered from being part of an MCS taskforce – (not intended as clinical guidance).

Early Immune System Research in Multiple Chemical Sensitivity (MCS)

What past studies found — and what it may mean today

In the 1980s and 1990s, several research groups investigated whether the immune system might play a role in Multiple Chemical Sensitivity (MCS). Although this research is now quite old and has not been followed up extensively in recent years, many people with MCS may find it interesting to know what these early studies showed.

Below is a simple summary of the key findings.

1. Autoantibodies in Some MCS Patients

Autoantibodies are immune proteins that react against a person’s own tissues. In one study from 1997, about one-third of people with MCS had autoantibodies such as:

• antibodies against myelin (a protective nerve coating)
• anti–smooth muscle
• anti–liver tissue
• anti–kidney brush border
• rheumatoid factor

Other research found anti-myelin antibodies in a high proportion of participants with MCS. This does not prove nerve damage, but it suggests the immune system may be reacting differently in some people.

2. Chemical Exposure May Influence the Immune System

Research from the early 1990s reported that certain chemicals can affect immune function. These effects included changes to immune cell types and increased immune activation in some individuals. While these findings are general and not specific to MCS, they raised interest in possible links between chemical exposure and immune changes.

3. A 1992 Workshop Proposed Possible Immune Markers for MCS

At a scientific workshop in 1992, researchers reported several patterns in people diagnosed with MCS:

• 64% had unusual levels of chemical antibodies
• 17% had a positive ANA test (ANA is an autoimmune screening tool; typical background rates are around 3–4%)
• Other autoantibodies were also more common than usual
• A type of immune cell known as TA1 was frequently elevated

The researchers suggested that if several body systems show abnormalities (e.g., nervous system tests, immune markers, lung function), this could support a diagnosis of MCS. These ideas were early and experimental; they were never adopted as official guidelines.

4. Early Attempts to Develop “Chemical Antibody” Tests

In the late 1980s and early 1990s, immunologist A. Vojdani (also spelled Wojdani) developed laboratory tests to measure antibodies against various chemicals.
These tests were commercialised at the time, but it is unclear whether they are still available or used today.

5. What This Means for People With MCS Today

It’s important to know that:

• These studies are 30–40 years old
• There has not been much follow-up research to confirm or update their findings
• The immune system may be involved in MCS, but scientists have not reached a clear consensus

Still, these early studies show that researchers were actively exploring potential biological markers of MCS even decades ago. Many people with MCS may find it reassuring that immune differences have been documented in research, even if more work is needed.

In summary

Early scientific work suggested that some people with MCS show:

• higher levels of certain autoantibodies
• unusual immune cell patterns
• antibodies to chemicals
• signs of immune activation

These findings have not been fully confirmed by modern research, but they remain an important part of the history of MCS science.